Genscript Biotech Corporation ( GNNSF) - Key Metrics
GNNSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.20 | -$0.23 | ? | ? |
| 2025Q2 | $0.44 | -$0.02 | $0.20 | $0.17 |
| 2024Q4 | $0.02 | $1.44 | ? | ? |
| 2024Q2 | $0.27 | -$0.08 | $0.04 | -$0.03 |
| 2023Q4 | $0.22 | $0 | -$0.05 | -$0.14 |
GNNSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -1.72 |
| 2025Q2 | ? | -21.83 |
| 2024Q4 | ? | 0.22 |
| 2024Q2 | ? | -3.34 |
| 2023Q4 | ? | -640.00 |
GNNSF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q2 | 9.02% | ? |
| 2024Q4 | ? | ? |
| 2024Q2 | -2.32% | ? |
| 2023Q4 | -5.60% | ? |
GNNSF
Price: $1.60
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.25 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.5 billion